Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis : pooled analysis across six clinical trials

Autor: Strober, B.E., Gottlieb, A.B., van de Kerkhof, P.C.M., Puig Sanz, Lluís., Bachelez, Hervé, Chouela, E., Imafuku, S., Thaçi, Diamant, Tan, H., Valdez, H., Gupta, P., Kaur, M., Frajzyngier, V., Wolk, R., Universitat Autònoma de Barcelona

Publikováno v: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
British Journal of Dermatology, 180, 1, pp. 67-75
The British Journal of Dermatology
British Journal of Dermatology, 180, 67-75

Summary Background Although existing psoriasis treatments are effective and well tolerated in many patients, there is still a need for new effective targeted treatment options. Tofacitinib is an oral Janus kinase inhibitor that has been investigated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee5e66f72d9032142b4d767329442c3f
https://ddd.uab.cat/record/222856

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Determinants of postoperative outcomes of female genital fistula repair surgery.

Autor: Barone MA, Frajzyngier V, Ruminjo J, Asiimwe F, Barry TH, Bello A, Danladi D, Ganda SO, Idris S, Inoussa M, Lynch M, Mussell F, Podder DC, Barone, Mark A, Frajzyngier, Vera, Ruminjo, Joseph, Asiimwe, Frank, Barry, Thierno Hamidou, Bello, Abubakar, Danladi, Dantani

Publikováno v: Obstetrics & Gynecology; Sep2012, Vol. 120 Issue 3, p524-531, 8p

I118 DEVELOPMENT AND TEST OF PROGNOSTIC SCORING SYSTEMS FOR SURGICAL CLOSURE OF GENITO-URINARY FISTULA

Autor: Frajzyngier, V., Li, G., Larson, E., Ruminjo, J., Barone, M.A.

Publikováno v: In International Journal of Gynecology and Obstetrics October 2012 119 Supplement 3:S190-S190